Rejection of Metastatic 4T1 Breast Cancer by Attenuation of Treg Cells in Combination With Immune Stimulation
Open Access
- 1 December 2007
- journal article
- Published by Elsevier in Molecular Therapy
- Vol. 15 (12) , 2194-2202
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Levels of circulating regulatory CD4+CD25+ T cells are decreased in breast cancer patients after vaccination with a HER2/neu peptide (E75) and GM-CSF vaccine★Breast Cancer Research and Treatment, 2006
- Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8+ T-Cell Responses and Tumor ImmunityCancer Research, 2006
- Regulatory T cells, tumour immunity and immunotherapyNature Reviews Immunology, 2006
- Impaired Allogeneic Activation and T-helper 1 Differentiation of Human Cord Blood Naive CD4 T CellsTransplantation and Cellular Therapy, 2006
- The systemic administration of Ig-4-1BB ligand in combination with IL-12 gene transfer eradicates hepatic colon carcinomaGene Therapy, 2005
- Triggering of OX40 (CD134) on CD4+CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITRBlood, 2005
- Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-LCancer Gene Therapy, 2004
- Cloning and characterization of GITR ligandGenes & Immunity, 2003
- T cell activation with systemic agonistic antibody versus local 4-1BB ligand gene delivery combined with interleukin-12 eradicate liver metastases of breast cancerGene Therapy, 2002
- Construction and Biological Characterization of an Interleukin-12 Fusion Protein (Flexi-12): Delivery to Acute Myeloid Leukemic Blasts Using Adeno-Associated VirusHuman Gene Therapy, 1997